Navamedic ASA – Mandatory notification of trade by primary insider

Publisert: 19.12.2024

NAVA: Financial calendar

Publisert: 04.12.2024

NAVA: Major shareholder disclosure in Navamedic ASA

Publisert: 20.11.2024

Navamedic ASA: Amendments to loan agreements with Observe Medical ASA

Publisert: 15.11.2024

Navamedic ASA: Mandatory notice of trade

Publisert: 06.11.2024

Navamedic launches Eroxon[®] in Finland

Publisert: 06.11.2024